Use of Inosine Monophosphate Dehydrogenase Activity Assay to Determine the Specificity of PARP-1 Inhibitors.
Use of Inosine Monophosphate Dehydrogenase Activity Assay to Determine the Specificity of PARP-1 Inhibitors.
复制标题
使用肌苷单磷酸脱氢酶活性测定确定 PARP-1 抑制剂的特异性。
DOI:
10.1007/978-1-4939-6993-7_22
复制
发表时间:
2017
期刊:
影响因子:
--
通讯作者:
Ji,Yingbiao
中科院分区:
文献类型:
--
作者:
Anthony,Sajitha;Peterson,JeffreyR;Ji,Yingbiao
Inosine monophosphate dehydrogenase (IMPDH) is a rate-limiting enzyme involved in purine nucleotide biosynthesis. It is responsible for catalyzing the oxidation of inosine monophosphate (IMP) into xanthosine monophosphate (XMP). Concurrently, the cofactor NAD+is reduced to NADH. Poly(ADP-ribose) polymerase 1 (PARP-1) also utilizes NAD+as a substrate to synthesize poly(ADP-ribose). It has been demonstrated that inhibition of PARP-1 activity can be an effective cancer therapeutic. However, most PARP-1 inhibitors, including olaparib, were developed as NAD+analogs. Therefore, these inhibitors likely interfere with other NAD+-dependent pathways such as the one involved in de novo purine metabolism. In this chapter, we describe a method to quantitatively measure IMPDH activity by taking advantage of the autofluorescence of the product NADH. We use this method to analyze the effects of olaparib and non-NAD+-like PARP-1 inhibitor (5F02) on IMPDH activity. We found that olaparib, unlike 5F02, significantly inhibits IMPDH activity in a dose-dependent manner. Our results suggest that IMPDH inhibition is an off-target effect of olaparib treatment. The consequences of this effect should be addressed by future clinical studies.
影响因子:
4
作者:
Ji, Yingbiao;Tulin, Alexei V.
通讯作者:
Tulin, Alexei V.